M. Gerdin, F. Mseeh, . Dubocovich, and . Ml, Mutagenesis studies of the human MT2 melatonin receptor, Biochemical Pharmacology, vol.66, issue.2, pp.315-320, 2003.
DOI : 10.1016/S0006-2952(03)00239-9

C. Gianesini, S. Hiragaki, V. Laurent, D. Hicks, and . Tosini, Cone Viability Is Affected by Disruption of Melatonin Receptors Signaling, Investigative Opthalmology & Visual Science, vol.57, issue.1, pp.94-104, 2016.
DOI : 10.1167/iovs.15-18235

E. Gitto, M. Karbownik, R. Reiter, . Tan, . Dx et al., Effects of Melatonin Treatment in Septic Newborns, Pediatric Research, vol.50, issue.6, pp.756-760, 2001.
DOI : 10.1203/00006450-200112000-00021

N. Green, C. Jackson, H. Iwamoto, . Tackenberg, . Mc et al., Photoperiod Programs Dorsal Raphe Serotonergic Neurons and Affective Behaviors, Current Biology, vol.25, issue.10, pp.1389-1394, 2015.
DOI : 10.1016/j.cub.2015.03.050

D. Heckman, M. Attia, . Behnam, . Mam, A. Mohsen et al., ,3-Dihydro-2H-isoindol-2yl)methyl]-melatonin-a novel MT2-selective melatonin receptor antagonist, Med Chem Commun, vol.21, issue.2, pp.991-994, 2011.

D. Hevia, P. Gonzalez-menendez, I. Quiros-gonzalez, A. Miar, A. Rodriguez-garcia et al., Melatonin uptake through glucose transporters: a new target for melatonin inhibition of cancer, Journal of Pineal Research, vol.74, issue.2, pp.234-250, 2015.
DOI : 10.1111/jpi.12210

C. Hotta, . Gazarini, . Ml, . Beraldo, . Fh et al., Calcium-dependent modulation by melatonin of the circadian rhythm in malarial parasites, Nat Cell Biol, vol.2, issue.7, pp.466-468, 2000.

Y. Hu, J. Zhu, K. Chan, and Y. Wong, Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT2-selective melatonin agonists: Improving metabolic stability, Bioorganic & Medicinal Chemistry, vol.21, issue.2, pp.547-552, 2013.
DOI : 10.1016/j.bmc.2012.10.060

A. Hunt, W. Alghoul, . Gillette, . Mu, . Dubocovich et al., Activation of MT2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock, Amer J Physiol Cell Physiol, vol.280, issue.1, pp.110-118, 2001.

A. Hutchinson, R. Hudson, . Dubocovich, and . Ml, melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/HeN mice, Journal of Pineal Research, vol.102, issue.Suppl 1, pp.399-409, 2012.
DOI : 10.1111/j.1600-079X.2012.01010.x

A. Jilg, J. Moek, . Weaver, . Dr, . Korf et al., Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling, European Journal of Neuroscience, vol.101, issue.11, pp.2845-2854, 2005.
DOI : 10.1111/j.1460-9568.2005.04485.x

X. Jin, . Gc, R. Pieschl, . Gribkoff, . Vk et al., Targeted Disruption of the Mouse Mel1b Melatonin Receptor, Molecular and Cellular Biology, vol.23, issue.3, pp.1054-1060, 2003.
DOI : 10.1128/MCB.23.3.1054-1060.2003

R. Jockers, P. Maurice, J. Boutin, and . Delagrange, Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?, British Journal of Pharmacology, vol.338, issue.Suppl 2, pp.1182-1195, 2008.
DOI : 10.1038/bjp.2008.184

J. Johnston, . Skene, and . Dj, 60 YEARS OF NEUROENDOCRINOLOGY: Regulation of mammalian neuroendocrine physiology and rhythms by melatonin, Journal of Endocrinology, vol.226, issue.2, pp.187-198, 2015.
DOI : 10.1530/JOE-15-0119

J. Johnston and M. Filizola, Beyond Standard Molecular Dynamics: Investigating the Molecular Mechanisms of G Protein-Coupled Receptors with Enhanced Molecular Dynamics Methods, Adv Exp Med Biol, vol.796, pp.95-125, 2014.
DOI : 10.1007/978-94-007-7423-0_6

N. Joshi, J. Biswas, C. Nath, and S. Singh, Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology, Molecular Neurobiology, vol.32, issue.6, pp.330-340, 2015.
DOI : 10.1371/journal.pbio.1001347

A. Journe, S. Habib, . Dodda, . Br, . Morcos et al., N1-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors, MedChemComm, vol.277, issue.6, pp.792-796, 2014.
DOI : 10.1039/c4md00079j

M. Kamal, F. Gbahou, J. Guillaume, A. Daulat, A. Benleulmi-chaachoua et al., Receptor Heteromers, Journal of Biological Chemistry, vol.290, issue.18, pp.11537-11546, 2015.
DOI : 10.1074/jbc.M114.559542

Y. Kang, . Zhou, . Xe, X. Gao, Y. He et al., Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser, Nature, vol.79, issue.7562, pp.561-567, 2015.
DOI : 10.1038/nature14656

A. Karamitri and R. Jockers, Exon Sequencing of G Protein-Coupled Receptor Genes and Perspectives for Disease Treatment, pp.313-332, 2014.
DOI : 10.1007/978-1-62703-779-2_17

A. Karamitri, N. Renault, N. Clement, J. Guillaume, and . Jockers, Receptor Variants with Type 2 Diabetes, Molecular Endocrinology, vol.27, issue.8, pp.1217-1233, 2013.
DOI : 10.1210/me.2013-1101

K. Kato, K. Hirai, K. Nishiyama, O. Uchikawa, K. Fukatsu et al., Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist, Neuropharmacology, vol.48, issue.2, pp.301-310, 2005.
DOI : 10.1016/j.neuropharm.2004.09.007

T. Koike, Y. Hoashi, T. Takai, M. Nakayama, N. Yukuhiro et al., -Selective Agonists, Journal of Medicinal Chemistry, vol.54, issue.9, pp.3436-3444, 2011.
DOI : 10.1021/jm200221q
URL : https://hal.archives-ouvertes.fr/in2p3-00022777

T. Kokkola, . Foord, . Sm, M. Watson, O. Vakkuri et al., Important amino acids for the function of the human MT1 melatonin receptor, Biochemical Pharmacology, vol.65, issue.9, pp.1463-1471, 2003.
DOI : 10.1016/S0006-2952(03)00113-8

D. Krause, J. Siuciak, . Dubocovich, and . Ml, Optic nerve transection decreases 2-[125I]iodomelatonin binding in the chick optic tectum, Brain Research, vol.590, issue.1-2, pp.325-328, 1992.
DOI : 10.1016/0006-8993(92)91115-U

A. Naskar, V. Prabhakar, R. Singh, D. Dutta, . Mohanakumar et al., Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice, Journal of Pineal Research, vol.337, issue.3, pp.262-274, 2015.
DOI : 10.1111/jpi.12212

M. Nelson, D. Wegmann, . Ehm, . Mg, D. Kessner et al., An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People, Science, vol.337, issue.6090, pp.100-104, 2012.
DOI : 10.1126/science.1217876

R. Nonno, V. Lucini, G. Spadoni, M. Pannacci, A. Croce et al., A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties, Journal of Pineal Research, vol.29, issue.4, pp.234-240, 2000.
DOI : 10.1034/j.1600-0633.2002.290406.x

O. Nosjean, M. Ferro, F. Cogé, P. Beauverger, J. Henlin et al., Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2, Journal of Biological Chemistry, vol.275, issue.40, pp.31311-31317, 2000.
DOI : 10.1074/jbc.M005141200

O. , G. Delic, V. Bradshaw, . Pc, and . Olcese, Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AbetaPP(swe)/PS1 mice, Mol Neurodegener, vol.10, p.27, 2015.

O. , G. Pilli, J. Kumar, . Ss, and . Olcese, Genetic deletion of MT1/MT2 melatonin receptors enhances murine cognitive and motor performance, Neuroscience, vol.277, pp.506-521, 2014.

R. Ochoa-sanchez, S. Comai, B. Lacoste, F. Bambico, S. Dominguez-lopez et al., Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand, Journal of Neuroscience, vol.31, issue.50, pp.31-18439, 2011.
DOI : 10.1523/JNEUROSCI.2676-11.2011

T. Okada, Y. Fujiyoshi, M. Silow, J. Navarro, E. Landau et al., Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography, Proceedings of the National Academy of Sciences, vol.99, issue.9, pp.5982-5987, 2002.
DOI : 10.1073/pnas.082666399

T. Okada, M. Sugihara, A. Bondar, M. Elstner, P. Entel et al., The Retinal Conformation and its Environment in Rhodopsin in Light of a New 2.2?? Crystal Structure, Journal of Molecular Biology, vol.342, issue.2, pp.571-583, 2004.
DOI : 10.1016/j.jmb.2004.07.044

J. Olcese, C. Cao, T. Mori, . Mamcarz, . Mb et al., Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease, Journal of Pineal Research, vol.154, issue.1, pp.82-96, 2009.
DOI : 10.1111/j.1600-079X.2009.00692.x

G. Ortiz, F. Pacheco-moises, V. Gomez-rodriguez, E. Gonzalez-renovato, E. Torres-sanchez et al., AC (2013) Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl- 4, Metab Brain Dis, vol.28, issue.4, pp.6-705, 2003.

S. Owino, S. Contreras-alcantara, K. Baba, and . Tosini, Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks, PLOS ONE, vol.15, issue.3, 2016.
DOI : 10.1371/journal.pone.0148214.t005

D. Pala, T. Beuming, W. Sherman, A. Lodola, S. Rivara et al., Melatonin Receptor: Influence of Template Choice and Structural Refinement, Journal of Chemical Information and Modeling, vol.53, issue.4, pp.821-835, 2013.
DOI : 10.1021/ci4000147

K. Palczewski, T. Kumasaka, T. Hori, C. Behnke, H. Motoshima et al., Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor, Science, vol.289, issue.5480, pp.739-745, 2000.
DOI : 10.1126/science.289.5480.739

C. Peng, J. Hu, D. Liu, . Hong, . Xp et al., Disease-modified glycogen synthase kinase-3?? intervention by melatonin arrests the pathology and memory deficits in an Alzheimer's animal model, Neurobiology of Aging, vol.34, issue.6, pp.1555-1563, 2013.
DOI : 10.1016/j.neurobiolaging.2012.12.010

M. Pfeffer, A. Rauch, H. Korf, and V. Gall, The Endogenous Melatonin (MT) Signal Facilitates Reentrainment of the Circadian System to Light-Induced Phase Advances by Acting Upon MT2 Receptors, Chronobiology International, vol.288, issue.4, pp.415-429, 2012.
DOI : 10.1111/j.1755-5949.2010.00197.x

L. Pinato, S. Da-silveira-cruz-machado, . Franco, . Dg, . Campos et al., Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis, Brain Structure and Function, vol.44, issue.2, pp.827-840, 2015.
DOI : 10.1007/s00429-013-0686-4

M. Pires-lapa, . Tamura, . Ek, E. Salustiano, and . Markus, Melatonin synthesis in human colostrum mononuclear cells enhances dectin-1-mediated phagocytosis by mononuclear cells, Journal of Pineal Research, vol.430, issue.Suppl 3, pp.240-246, 2013.
DOI : 10.1111/jpi.12066

S. Poissonnier-durieux, M. Ettaoussi, B. Peres, J. Boutin, V. Audinot et al., Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands, Bioorganic & Medicinal Chemistry, vol.16, issue.18, pp.8339-8348, 2008.
DOI : 10.1016/j.bmc.2008.08.052

G. Pontes, E. Cardoso, . Carneiro-sampaio, . Mm, and . Markus, Pineal melatonin and the innate immune response: the TNF-? increase after cesarean section suppresses nocturnal melatonin production, Journal of Pineal Research, vol.145, issue.4, pp.365-371, 2007.
DOI : 10.1016/S1359-6101(97)00021-X

C. Prada, . Udin, . Sb, . Wiechmann, . Af et al., Stimulation of Melatonin Receptors Decreases Calcium Levels in Xenopus Tectal Cells by Activating GABAC Receptors, Journal of Neurophysiology, vol.94, issue.2, pp.968-978, 2005.
DOI : 10.1152/jn.01286.2004

I. Prokopenko, C. Langenberg, J. Florez, R. Saxena, N. Soranzo et al., Variants in MTNR1B influence fasting glucose levels, Nature Genetics, vol.271, issue.1, pp.77-81, 2009.
DOI : 10.1111/j.1600-079X.2007.00426.x

D. Provasi, . Artacho, . Mc, A. Negri, J. Mobarec et al., Ligand-Induced Modulation of the Free-Energy Landscape of G Protein-Coupled Receptors Explored by Adaptive Biasing Techniques, PLoS Computational Biology, vol.22, issue.10, p.1002193, 2011.
DOI : 10.1371/journal.pcbi.1002193.s011

G. Racagni, M. Riva, R. Molteni, L. Musazzi, F. Calabrese et al., Mode of action of agomelatine: Synergy between melatonergic and 5-HT(2C) receptors, World J Biol Psychiatry, 2011.

S. Rajaratnam, . Polymeropoulos, . Mh, . Fisher, . Dm et al., Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials, The Lancet, vol.373, issue.9662, pp.482-491, 2009.
DOI : 10.1016/S0140-6736(08)61812-7

S. Rasmussen, . Choi, . Hj, J. Fung, E. Pardon et al., Structure of a nanobody-stabilized active state of the ??2 adrenoceptor, Nature, vol.104, issue.7329, pp.175-180, 2011.
DOI : 10.1038/nature09648

S. Rasmussen, . Devree, . Bt, Y. Zou, A. Kruse et al., Crystal structure of the ??2 adrenergic receptor???Gs protein complex, Nature, vol.61, issue.7366, pp.549-555, 2011.
DOI : 10.1038/nature10361

O. Rawashdeh, R. Hudson, I. Stepien, . Dubocovich, and . Ml, Circadian Periods of Sensitivity for Ramelteon on the onset of Running-wheel Activity and the Peak of Suprachiasmatic Nucleus Neuronal Firing Rhythms in C3H/HeN Mice, Chronobiology International, vol.60, issue.1, pp.31-38, 2011.
DOI : 10.1016/j.brainres.2004.08.035

A. Ressmeyer, J. Mayo, V. Zelosko, . Sainz, . Rm et al., -acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction, Redox Report, vol.133, issue.4, pp.205-213, 2003.
DOI : 10.1142/9789812811158_0063

S. Rivara, A. Lodola, M. Mor, A. Bedini, G. Spadoni et al., -(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands, Journal of Medicinal Chemistry, vol.50, issue.26, pp.6618-6626, 2007.
DOI : 10.1021/jm700957j

S. Rivara, S. Lorenzi, M. Mor, . Plazzi, . Pv et al., Receptor Models, Journal of Medicinal Chemistry, vol.48, issue.12, pp.4049-4060, 2005.
DOI : 10.1021/jm048956y

S. Rivara, D. Pala, A. Lodola, M. Mor, V. Lucini et al., -Substituted)anilino]alkyl}amides, ChemMedChem, vol.97, issue.11, pp.1954-1964, 2012.
DOI : 10.1002/cmdc.201200303
URL : https://hal.archives-ouvertes.fr/hal-00958574

R. Rosen, . Hu, . Dn, V. Perez, K. Tai et al., Urinary 6- sulfatoxymelatonin level in age-related macular degeneration patients, Mol Vis, vol.15, pp.1673-1679, 2009.

S. Lde, F. Mesquita, F. De-sousa, . Pr, J. Silva et al., The melatonin analog 5-MCA-NAT increases endogenous dopamine levels by binding NRH:quinone reductase enzyme in the developing chick retina, Int J Dev Neurosci, vol.38, pp.119-126, 2014.

E. Savaskan, G. Olivieri, F. Meier, L. Brydon, R. Jockers et al., Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients, Journal of Pineal Research, vol.32, issue.1, 2002.
DOI : 10.1034/j.1600-079x.2002.00841.x

E. Savaskan, C. Schnitzler, C. Schroder, C. Cajochen, F. Muller-spahn et al., Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine, The International Journal of Neuropsychopharmacology, vol.9, issue.05, pp.507-516
DOI : 10.1017/S1461145705006036

P. Scheerer, J. Park, . Hildebrand, . Pw, Y. Kim et al., Crystal structure of opsin in its G-protein-interacting conformation, Nature, vol.8, issue.7212, pp.497-502, 2008.
DOI : 10.1038/nature07330

A. Sengupta, K. Baba, F. Mazzoni, . Pozdeyev, . Nv et al., Localization of Melatonin Receptor 1 in Mouse Retina and Its Role in the Circadian Regulation of the Electroretinogram and Dopamine Levels, PLoS ONE, vol.72, issue.9, p.24483, 2011.
DOI : 10.1371/journal.pone.0024483.g005

S. Sharma and C. Haldar, during reproductively active phase, International Journal of Radiation Biology, vol.23, issue.1, pp.411-419, 2006.
DOI : 10.1080/09553000600774105

P. Sheynzon, . Korf, and . Hw, Targeted deletions of Mel1a and Mel1b melatonin receptors affect pCREB levels in lactotroph and pars intermedia cells of mice, Neuroscience Letters, vol.407, issue.1, pp.48-52, 2006.
DOI : 10.1016/j.neulet.2006.08.016

I. Shin, . Shin, . Nr, . Park, . Jw et al., Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling, Journal of Pineal Research, vol.48, issue.1, pp.50-60, 2015.
DOI : 10.1111/jpi.12192

M. Soundararajan, . Willard, . Fs, . Kimple, . Aj et al., Structural diversity in the RGS domain and its interaction with heterotrimeric G protein ??-subunits, Proceedings of the National Academy of Sciences, vol.105, issue.17, pp.6457-6462, 2008.
DOI : 10.1073/pnas.0801508105

G. Spadoni, A. Bedini, S. Lucarini, M. Mari, . Caignard et al., Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines, Journal of Medicinal Chemistry, vol.58, issue.18, pp.7512-7525, 2015.
DOI : 10.1021/acs.jmedchem.5b01066

G. Spadoni, A. Bedini, P. Orlando, S. Lucarini, G. Tarzia et al., Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: Synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors, Bioorganic & Medicinal Chemistry, vol.19, issue.16, pp.4910-4916, 2011.
DOI : 10.1016/j.bmc.2011.06.063

I. Stumpf, E. Muhlbauer, and E. Peschke, Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic ??-cells, Journal of Pineal Research, vol.66, issue.3, pp.318-327, 2008.
DOI : 10.1111/j.1600-079X.2008.00593.x

D. Sugden, . Chong, . Nw, and . Lewis, Structural requirements at the melatonin receptor, British Journal of Pharmacology, vol.35, issue.suppl., 1995.
DOI : 10.1111/j.1476-5381.1995.tb17184.x

D. Sugden, . Yeh, . Lk, . Teh, and . Mt, Design of subtype selective melatonin receptor agonists and antagonists, Reproduction Nutrition Development, vol.39, issue.3, pp.335-344, 1999.
DOI : 10.1051/rnd:19990306
URL : https://hal.archives-ouvertes.fr/hal-00900305

E. Tamura, P. Fernandes, M. Marcola, S. Da-silveira-cruz-machado, and . Markus, Long-Lasting Priming of Endothelial Cells by Plasma Melatonin Levels, PLoS ONE, vol.72, issue.11, p.13958, 2010.
DOI : 10.1371/journal.pone.0013958.g008

D. Tan, L. Manchester, E. Esteban-zubero, Z. Zhou, and R. Reiter, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules, vol.20, issue.10, pp.18886-18906, 2015.
DOI : 10.3390/molecules201018886

D. Tan, . Manchester, . Lc, . Terron, . Mp et al., One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?, Journal of Pineal Research, vol.121, issue.1, pp.28-42, 2007.
DOI : 10.1016/j.jneuroim.2005.05.002

J. Tchekalarova, Z. Nenchovska, D. Atanasova, M. Atanasova, L. Kortenska et al., Consequences of long-term treatment with agomelatine on depressive-like behavior and neurobiological abnormalities in pinealectomized rats, Behavioural Brain Research, vol.302, pp.11-28, 2016.
DOI : 10.1016/j.bbr.2015.12.043

G. Tosini, K. Baba, C. Hwang, . Iuvone, and . Pm, Melatonin: An underappreciated player in retinal physiology and pathophysiology, Experimental Eye Research, vol.103, pp.82-89, 2012.
DOI : 10.1016/j.exer.2012.08.009

G. Tosini, S. Owino, J. Guillaume, and . Jockers, Understanding melatonin receptor pharmacology: Latest insights from mouse models, and their relevance to human disease, BioEssays, vol.29, issue.8, pp.778-787, 2014.
DOI : 10.1002/bies.201400017

O. Uchikawa, K. Fukatsu, R. Tokunoh, M. Kawada, K. Matsumoto et al., Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists, Journal of Medicinal Chemistry, vol.45, issue.19, pp.4222-4239, 2002.
DOI : 10.1021/jm0201159

O. Vakkuri, J. Leppaluoto, and . Vuolteenaho, Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer, European Journal of Endocrinology, vol.106, issue.2, pp.152-157, 1984.
DOI : 10.1530/acta.0.1060152

. Van-wamelen, . Dj, N. Aziz, J. Anink, R. Van-steenhoven et al., Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease, SLEEP, vol.36, issue.1, pp.117-125, 2013.
DOI : 10.5665/sleep.2314

. Van-wamelen, . Dj, R. Roos, and N. Aziz, Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease, Neurodegenerative Disease Management, vol.5, issue.6, pp.549-559, 2015.
DOI : 10.2217/nmt.15.45

J. Vanecek, Melatonin Binding Sites, Journal of Neurochemistry, vol.106, issue.5, pp.1436-1440, 1988.
DOI : 10.1016/0014-5793(88)80599-4

L. Vincent, W. Cohen, P. Delagrange, J. Boutin, and . Nosjean, -acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand, Journal of Pineal Research, vol.41, issue.3, pp.222-229, 2010.
DOI : 10.1111/j.1600-079X.2010.00746.x
URL : https://hal.archives-ouvertes.fr/hal-00807552

V. Gall, C. Garabette, . Ml, C. Kell, S. Frenzel et al., Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin, Nature Neuroscience, vol.5, issue.3, pp.234-238, 2002.
DOI : 10.1038/nn806

A. Voronkov, . Ivanov, . Aa, . Baskin, . Ii et al., Molecular Modeling Study of the Mechanism of Ligand Binding to Human Melatonin Receptors, Doklady Biochemistry and Biophysics, vol.39, issue.6, pp.284-288, 2005.
DOI : 10.1007/s10628-005-0093-8

A. Wade, M. Farmer, G. Harari, N. Fund, M. Laudon et al., Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial, Clin Interv Aging, vol.9, pp.947-961, 2014.

L. Wang, N. Suthana, D. Chaudhury, . Weaver, . Dr et al., Melatonin inhibits hippocampal long-term potentiation, European Journal of Neuroscience, vol.57, issue.9, pp.2231-2237, 2005.
DOI : 10.1111/j.1460-9568.2005.04408.x

X. Wang, A. Sirianni, Z. Pei, K. Cormier, . Smith et al., The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity, Journal of Neuroscience, vol.31, issue.41, pp.31-14496, 2011.
DOI : 10.1523/JNEUROSCI.3059-11.2011

Z. Weil, J. Borniger, Y. Cisse, and A. Salloum, Neuroendocrine control of photoperiodic changes in immune function, Frontiers in Neuroendocrinology, vol.37, pp.108-118, 2015.
DOI : 10.1016/j.yfrne.2014.10.001

J. Weishaupt, C. Bartels, E. Polking, J. Dietrich, G. Rohde et al., Reduced oxidative damage in ALS by high-dose enteral melatonin treatment, Journal of Pineal Research, vol.17, issue.2, pp.313-323, 2006.
DOI : 10.1038/nature03180

Y. Wu, J. Zhou, J. Van-heerikhuize, R. Jockers, . Swaab et al., Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer's disease, Neurobiology of Aging, vol.28, issue.8, pp.1239-1247, 2007.
DOI : 10.1016/j.neurobiolaging.2006.06.002

S. Yadav and C. Haldar, Reciprocal interaction between melatonin receptors (Mel1a, Mel1b, and Mel1c) and androgen receptor (AR) expression in immunoregulation of a seasonally breeding bird, Perdicula asiatica: Role of photoperiod, Journal of Photochemistry and Photobiology B: Biology, vol.122, pp.52-60, 2013.
DOI : 10.1016/j.jphotobiol.2013.03.005

S. Yasuo, T. Yoshimura, S. Ebihara, . Korf, and . Hw, Melatonin Transmits Photoperiodic Signals through the MT1 Melatonin Receptor, Journal of Neuroscience, vol.29, issue.9, pp.2885-2889, 2009.
DOI : 10.1523/JNEUROSCI.0145-09.2009

C. Zavala-oseguera, A. Galano, and . Merino, Computational Study on the Kinetics and Mechanism of the Carbaryl + OH Reaction, The Journal of Physical Chemistry A, vol.118, issue.36, pp.7776-7781, 2014.
DOI : 10.1021/jp507244s

O. Zefirova, T. Baranova, . Ivanova, . Aa, . Ivanov et al., Application of the bridgehead fragments for the design of conformationally restricted melatonin analogues, Bioorganic Chemistry, vol.39, issue.2, pp.67-72, 2011.
DOI : 10.1016/j.bioorg.2011.02.002

W. Zhang, . Chen, . Xy, . Su, . Sw et al., Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials, Neurological Sciences, vol.72, issue.6, pp.57-65, 2016.
DOI : 10.1007/s10072-015-2357-0

Y. Zhang, A. Cook, J. Kim, . Baranov, . Sv et al., Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis, Neurobiology of Disease, vol.55, pp.26-35, 2013.
DOI : 10.1016/j.nbd.2013.03.008

J. Zhou, R. Liu, W. Kamphorst, M. Hofman, . Swaab et al., Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels, Journal of Pineal Research, vol.25, issue.2, pp.125-130, 2003.
DOI : 10.1034/j.1600-079X.2003.01897.x

N. Zisapel, Y. Egozi, and M. Laudon, Circadian Variations in the Inhibition of Dopamine Release from Adult and Newborn Rat Hypothalamus by Melatonin, Neuroendocrinology, vol.40, issue.2, pp.102-108, 1985.
DOI : 10.1159/000124062

N. Zisapel and M. Laudon, Dopamine release induced by electrical field stimulation of rat hypothalamus invitro: Inhibition by melatonin, Biochemical and Biophysical Research Communications, vol.104, issue.4, pp.1610-1616, 1982.
DOI : 10.1016/0006-291X(82)91437-1

D. Zlotos, Recent Progress in the Development of Agonists and Antagonists for Melatonin Receptors, Current Medicinal Chemistry, vol.19, issue.21, pp.3532-3549, 2012.
DOI : 10.2174/092986712801323153

D. Zlotos, M. Attia, J. Julius, S. Sethi, and P. Witt-enderby, -Selective Melatonin Receptor Antagonists, Journal of Medicinal Chemistry, vol.52, issue.3, pp.826-833, 2009.
DOI : 10.1021/jm800974d
URL : https://hal.archives-ouvertes.fr/inserm-01335656

D. Zlotos, R. Jockers, E. Cecon, S. Rivara, and . Witt-enderby, Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential, Journal of Medicinal Chemistry, vol.57, issue.8, pp.3161-3185
DOI : 10.1021/jm401343c

D. Zlotos, N. Riad, . Dodda, . Br, and P. Witt-enderby, selectivity, Med. Chem. Commun., vol.2, issue.3, pp.1340-1344, 2015.
DOI : 10.1039/C5MD00190K